Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 101–200 of 1,003
N-Linked Glycosylation of Folded Proteins by the Bacterial Oligosaccharyltransferase
Kowarik, M., Numao, S., Feldman, M. F., Schulz, B. L., Callewaert, N., Kiermaier, E., Catrein, I., & Aebi, M. (2006) · Science · doi:10.1126/science.1134351 · Cited by 221
Mass spectrometry in the analysis of N-linked and O-linked glycans
North, S. J., Hitchen, P. G., Haslam, S. M., & Dell, A. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.05.005 · Cited by 221
Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment
Martínez-Carmona, M., Lozano, D., Colilla, M., & Vallet-Regí, M. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.007 · Cited by 220
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity
Thomann, M., Schlothauer, T., Dashivets, T., Malik, S., Avenal, C., Bulau, P., Rüger, P., & Reusch, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134949 · Cited by 220
“It is not always clear if glycan patterns of samples used in previous studies might have had differences in other glycan species apart from sialic acid, since complete glycan analysis has not been shown after sample preparation, such as lectin fractionation [15].”
BackgroundResultA prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C. A. M., Visser, R., Einarsdottir, H. K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A. M., et al. (2014) · Blood · doi:10.1182/blood-2013-09-527978 · Cited by 220
The Structural Role of Antibody N-Glycosylation in Receptor Interactions
Subedi, G. P., & Barb, A. W. (2015) · Structure · doi:10.1016/j.str.2015.06.015 · Cited by 216
General mechanism for modulating immunoglobulin effector function
Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 218
“It is notable that only the α2,6 configuration of the sialic acid–galactose linkage can reasonably accommodate this interaction and bring the carbohydrate potentially in contact with the receptor, consistent with the absolute requirement for α2,6 sialylation of the Fc to facilitate DC-SIGN binding (9, 10).”
BackgroundSelf-citationMimura, Y., Katoh, T., Saldova, R., O’Flaherty, R., Izumi, T., Mimura-Kimura, Y., Utsunomiya, T., Mizukami, Y., Yamamoto, K., Matsumoto, T., et al. (2018) · Protein & Cell · doi:10.1007/s13238-017-0433-3 · Cited by 217
Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 213
Role of IgG3 in Infectious Diseases
Damelang, T., Rogerson, S. J., Kent, S. J., & Chung, A. W. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.005 · Cited by 213
Recent advances in technology supporting biopharmaceutical production from mammalian cells
Butler, M., & Meneses-Acosta, A. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4451-z · Cited by 210
Pinho, S. S., Alves, I., Gaifem, J., & Rabinovich, G. A. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01074-1 · Cited by 206
Polarized immune responses differentially regulate cancer development
Johansson, M., DeNardo, D. G., & Coussens, L. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00600.x · Cited by 209
“When investigated further, it was found that glycolytic modifications through sialylation of Fc regions of IgG reduce binding affinities toward FcgRs and thereby inhibit pro-inflammatory activities of IgG, and in contrast, reduction of sialylation, upon antigen challenge, switches the immune response pathway from anti…”
BackgroundFcγR Binding and ADCC Activity of Human IgG Allotypes
de Taeye, S. W., Bentlage, A. E. H., Mebius, M. M., Meesters, J. I., Lissenberg-Thunnissen, S., Falck, D., Sénard, T., Salehi, N., Wuhrer, M., Schuurman, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00740 · Cited by 206
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease
Pagan, J. D., Kitaoka, M., & Anthony, R. M. (2018) · Cell · doi:10.1016/j.cell.2017.11.041 · Cited by 204
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Baković, M. P., Selman, M. H. J., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A. M., Lauc, G., & Wuhrer, M. (2013) · Journal of Proteome Research · doi:10.1021/pr300887z · Cited by 204
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Wang, T. T., Maamary, J., Tan, G. S., Bournazos, S., Davis, C. W., Krammer, F., Schlesinger, S. J., Palese, P., Ahmed, R., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.06.026 · Cited by 201
Self-citationA common glycan structure on immunoglobulin G for enhancement of effector functions
Lin, C.-W., Tsai, M.-H., Li, S.-T., Tsai, T.-I., Chu, K.-C., Liu, Y.-C., Lai, M.-Y., Wu, C.-Y., Tseng, Y.-C., Shivatare, S. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513456112 · Cited by 200
Modulation of the cellular immune system by intravenous immunoglobulin
Tha-In, T., Bayry, J., Metselaar, H. J., Kaveri, S. V., & Kwekkeboom, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.004 · Cited by 199
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Vaccari, M., Gordon, S. N., Fourati, S., Schifanella, L., Liyanage, N. P. M., Cameron, M., Keele, B. F., Shen, X., Tomaras, G. D., Billings, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4105 · Cited by 199
The history of IgG glycosylation and where we are now
Cobb, B. A. (2020) · Glycobiology · doi:10.1093/glycob/cwz065 · Cited by 193
Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23075 · Cited by 193
Functional diversification of IgGs through Fc glycosylation
Wang, T. T., & Ravetch, J. V. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130029 · Cited by 192
Self-citationNovel roles for the IgG Fc glycan
Anthony, R. M., Wermeling, F., & Ravetch, J. V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06305.x · Cited by 186
Self-citationWada, R., Matsui, M., & Kawasaki, N. (2019) · mAbs · doi:10.1080/19420862.2018.1551044 · Cited by 186
Fcγ Receptor Function and the Design of Vaccination Strategies
Bournazos, S., & Ravetch, J. V. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.009 · Cited by 185
Self-citationAntibody glycosylation in inflammation, disease and vaccination
Alter, G., Ottenhoff, T. H. M., & Joosten, S. A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.003 · Cited by 186
Advances in antibody-based therapy in oncology
Zinn, S., Vazquez-Lombardi, R., Zimmermann, C., Sapra, P., Jermutus, L., & Christ, D. (2023) · Nature Cancer · doi:10.1038/s43018-023-00516-z · Cited by 184
Mechanisms of disease: The human N-glycome
Lauc, G., Pezer, M., Rudan, I., & Campbell, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.016 · Cited by 184
“This is confirmed by the finding that the hyper-sialylated Fc fraction, recognized by the DC-SIGN (CD209) receptor, is responsible for the anti-inflammatory property of intravenous immunoglobulins administered at high doses (g/kg) [56,57].”
BackgroundToghi Eshghi, S., Shah, P., Yang, W., Li, X., & Zhang, H. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00024 · Cited by 182
Biological Functions and Analytical Strategies of Sialic Acids in Tumor
Zhou, X., Yang, G., & Guan, F. (2020) · Cells · doi:10.3390/cells9020273 · Cited by 182
Seeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 179
Self-citationAglycosylated immunoglobulin G1variants productively engage activating Fc receptors
Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 177
Self-citationStructural and functional characteristics of bovine milk protein glycosylation
O'Riordan, N., Kane, M., Joshi, L., & Hickey, R. M. (2014) · Glycobiology · doi:10.1093/glycob/cwt162 · Cited by 176
The choice of mammalian cell host and possibilities for glycosylation engineering
Butler, M., & Spearman, M. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.06.010 · Cited by 175
“This can be shown by the modification of sialylation profiles of immunoglobulins during inflammatory or anti-inflammatory changes that occur in vivo [37].”
BackgroundEmerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function
Zhuo, Y., & Bellis, S. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.191429 · Cited by 174
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
Subedi, G. P., & Barb, A. W. (2016) · mAbs · doi:10.1080/19420862.2016.1218586 · Cited by 174
Glycoproteomic Analysis of Antibodies
Zauner, G., Selman, M. H. J., Bondt, A., Rombouts, Y., Blank, D., Deelder, A. M., & Wuhrer, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.026005 · Cited by 172
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis
Ohmi, Y., Ise, W., Harazono, A., Takakura, D., Fukuyama, H., Baba, Y., Narazaki, M., Shoda, H., Takahashi, N., Ohkawa, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11205 · Cited by 170
The Ligands for Human IgG and Their Effector Functions
de Taeye, S. W., Rispens, T., & Vidarsson, G. (2019) · Antibodies · doi:10.3390/antib8020030 · Cited by 170
Human IgG4: a structural perspective
Davies, A. M., & Sutton, B. J. (2015) · Immunological Reviews · doi:10.1111/imr.12349 · Cited by 170
Optimization of Fc-mediated effector functions of monoclonal antibodies
Strohl, W. R. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.011 · Cited by 168
Reusch, D., Haberger, M., Maier, B., Maier, M., Kloseck, R., Zimmermann, B., Hook, M., Szabo, Z., Tep, S., Wegstein, J., et al. (2015) · mAbs · doi:10.4161/19420862.2014.986000 · Cited by 168
Bondt, A., Selman, M. H. J., Deelder, A. M., Hazes, J. M. W., Willemsen, S. P., Wuhrer, M., & Dolhain, R. J. E. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400589m · Cited by 168
Inhibitory ITAMs as novel regulators of immunity
Blank, U., Launay, P., Benhamou, M., & Monteiro, R. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00832.x · Cited by 167
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases
Šimurina, M., de Haan, N., Vučković, F., Kennedy, N. A., Štambuk, J., Falck, D., Trbojević-Akmačić, I., Clerc, F., Razdorov, G., Khon, A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.002 · Cited by 167
Zou, G., Ochiai, H., Huang, W., Yang, Q., Li, C., & Wang, L.-X. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208390n · Cited by 166
Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
Trbojević Akmačić, I., Ventham, N. T., Theodoratou, E., Vučković, F., Kennedy, N. A., Krištić, J., Nimmo, E. R., Kalla, R., Drummond, H., Štambuk, J., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000372 · Cited by 166
Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health
Plomp, R., Ruhaak, L. R., Uh, H.-W., Reiding, K. R., Selman, M., Houwing-Duistermaat, J. J., Slagboom, P. E., Beekman, M., & Wuhrer, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12495-0 · Cited by 164
Chemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions
Wang, L.-X., & Amin, M. N. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.001 · Cited by 163
The role of glycosylation in IBD
Theodoratou, E., Campbell, H., Ventham, N. T., Kolarich, D., Pučić-Baković, M., Zoldoš, V., Fernandes, D., Pemberton, I. K., Rudan, I., Kennedy, N. A., et al. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.78 · Cited by 162
Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli
Wang, J., Balog, C. I. A., Stavenhagen, K., Koeleman, C. A. M., Scherer, H. U., Selman, M. H. J., Deelder, A. M., Huizinga, T. W. J., Toes, R. E. M., & Wuhrer, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004655 · Cited by 162
Saldova, R., Wormald, M. R., Dwek, R. A., & Rudd, P. M. (2008) · Disease Markers · doi:10.1155/2008/601583 · Cited by 162
Yu, L., Li, X., Guo, Z., Zhang, X., & Liang, X. (2009) · Chemistry – A European Journal · doi:10.1002/chem.200902370 · Cited by 162
Veri, M., Gorlatov, S., Li, H., Burke, S., Johnson, S., Stavenhagen, J., Stein, K. E., Bonvini, E., & Koenig, S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02588.x · Cited by 157
Pentraxins in innate immunity: lessons from PTX3
Deban, L., Jaillon, S., Garlanda, C., Bottazzi, B., & Mantovani, A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1018-0 · Cited by 158
Cooper, N., & Arnold, D. M. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08076.x · Cited by 159
Chapter 4 Multitasking by Exploitation of Intracellular Transport Functions
Ward, E. S., & Ober, R. J. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(09)03004-1 · Cited by 156
Lee, S. C., Srivastava, R. M., López-Albaitero, A., Ferrone, S., & Ferris, R. L. (2011) · Immunologic Research · doi:10.1007/s12026-011-8231-0 · Cited by 156
“This differential sialyation may thus modulate the immunological responses against antigens [30].”
BackgroundChu, S. Y., Voštiar, I., Karki, S., Moore, G. L., Lazar, G. A., Pong, E., Joyce, P. F., Szymkowski, D. E., & Desjarlais, J. R. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.027 · Cited by 157
Changes in IgG and total plasma protein glycomes in acute systemic inflammation
Novokmet, M., Lukić, E., Vučković, F., Đurić, Ž., Keser, T., Rajšl, K., Remondini, D., Castellani, G., Gašparović, H., Gornik, O., et al. (2014) · Scientific Reports · doi:10.1038/srep04347 · Cited by 172
Glycosylation: impact, control and improvement during therapeutic protein production
Costa, A. R., Rodrigues, M. E., Henriques, M., Oliveira, R., & Azeredo, J. (2014) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.793649 · Cited by 155
Massoud, A. H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W. M., Piccirillo, C. A., & Mazer, B. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.029 · Cited by 161
Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
Ahmed, A. A., Giddens, J., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L.-X., & Bjorkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 154
Self-citationLu, J., Chu, J., Zou, Z., Hamacher, N. B., Rixon, M. W., & Sun, P. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418812112 · Cited by 152
Harvey, D. J. (2006) · Mass Spectrometry Reviews · doi:10.1002/mas.20080 · Cited by 153
Nimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 180
Self-citationComplement in the Initiation and Evolution of Rheumatoid Arthritis
Holers, V. M., & Banda, N. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01057 · Cited by 168
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
Gogesch, P., Dudek, S., van Zandbergen, G., Waibler, Z., & Anzaghe, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168947 · Cited by 172
Lectins: past, present and future1
Sharon, N. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361457 · Cited by 149
Fcγ receptor pathways during active and passive immunization
Bournazos, S., & Ravetch, J. V. (2015) · Immunological Reviews · doi:10.1111/imr.12343 · Cited by 146
Self-citationStructural and functional characterization of the trifunctional antibody catumaxomab
Chelius, D., Ruf, P., Gruber, P., Plöscher, M., Liedtke, R., Gansberger, E., Heß, J., Wasiliu, M., & Lindhofer, H. (2010) · mAbs · doi:10.4161/mabs.2.3.11791 · Cited by 152
Xie, H., Chakraborty, A., Ahn, J., Yu, Y. Q., Dakshinamoorthy, D. P., Gilar, M., Chen, W., Skilton, S. J., & Mazzeo, J. R. (2010) · mAbs · doi:10.4161/mabs.11986 · Cited by 145
Ruhaak, L. R., Hennig, R., Hühn, C., Borowiak, M., Dolhain, R. J. E. M., Deelder, A. M., Rapp, E., & Wuhrer, M. (2010) · Journal of Proteome Research · doi:10.1021/pr100802f · Cited by 145
Intravenous immunoglobulin therapy in rheumatic diseases
Bayry, J., Negi, V. S., & Kaveri, S. V. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.61 · Cited by 156
Emerging methods for the production of homogeneous human glycoproteins
Rich, J. R., & Withers, S. G. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.148 · Cited by 163
N-Glycosylation and Inflammation; the Not-So-Sweet Relation
Radovani, B., & Gudelj, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893365 · Cited by 162
The role of sialic acid as a modulator of the anti-inflammatory activity of IgG
Böhm, S., Schwab, I., Lux, A., & Nimmerjahn, F. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0308-x · Cited by 152
Self-citationVerhelst, X., Dias, A. M., Colombel, J., Vermeire, S., Vlierberghe, H. V., Callewaert, N., & Pinho, S. S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.060 · Cited by 159
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Parsons, T. B., Struwe, W. B., Gault, J., Yamamoto, K., Taylor, T. A., Raj, R., Wals, K., Mohammed, S., Robinson, C. V., Benesch, J. L. P., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201508723 · Cited by 153
Emerging Technologies for Making Glycan-Defined Glycoproteins
Wang, L., & Lomino, J. V. (2011) · ACS Chemical Biology · doi:10.1021/cb200429n · Cited by 144
Fcγ Receptor Heterogeneity in Leukocyte Functional Responses
Rosales, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00280 · Cited by 161
del Val, I. J., Kontoravdi, C., & Nagy, J. M. (2010) · Biotechnology Progress · doi:10.1002/btpr.470 · Cited by 139
The role and function of Fcγ receptors on myeloid cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138
“In contrast, the presence of terminal sialic acid residues is associated with reduced binding to type I FcγRs and preferential engagement of type II FcγRs (18, 27, 28), an effect attributed to the induction of a conformational change of the CH2 domains upon sialylation that affects type I and type II FcγR binding (5,…”
BackgroundSelf-citationImmune complexes regulate bone metabolism through FcRγ signalling
Negishi-Koga, T., Gober, H.-J., Sumiya, E., Komatsu, N., Okamoto, K., Sawa, S., Suematsu, A., Suda, T., Sato, K., Takai, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7637 · Cited by 137
Irvine, E. B., & Alter, G. (2020) · Glycobiology · doi:10.1093/glycob/cwaa018 · Cited by 151
Campbell, I. K., Miescher, S., Branch, D. R., Mott, P. J., Lazarus, A. H., Han, D., Maraskovsky, E., Zuercher, A. W., Neschadim, A., Leontyev, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301611 · Cited by 136
Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination
Selman, M. H. J., de Jong, S. E., Soonawala, D., Kroon, F. P., Adegnika, A. A., Deelder, A. M., Hokke, C. H., Yazdanbakhsh, M., & Wuhrer, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014563 · Cited by 136
Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
Cymer, F., Beck, H., Rohde, A., & Reusch, D. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.11.001 · Cited by 158
Boune, S., Hu, P., Epstein, A. L., & Khawli, L. A. (2020) · Antibodies · doi:10.3390/antib9020022 · Cited by 155
Chen, G., Wang, Y., Qiu, L., Qin, X., Liu, H., Wang, X., Wang, Y., Song, G., Li, F., Guo, Y., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.02.001 · Cited by 151
The mast cell IgG receptors and their roles in tissue inflammation
Malbec, O., & Daëron, M. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00510.x · Cited by 154
Glycoengineering of Antibodies for Modulating Functions
Wang, L., Tong, X., Li, C., Giddens, J. P., & Li, T. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012911 · Cited by 148
Understanding the Chemistry and Biology of Glycosylation with Glycan Synthesis
Krasnova, L., & Wong, C.-H. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034420 · Cited by 133
B-cell–independent sialylation of IgG
Jones, M. B., Oswald, D. M., Joshi, S., Whiteheart, S. W., Orlando, R., & Cobb, B. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523968113 · Cited by 134
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective
Desjarlais, J. R., Lazar, G. A., Zhukovsky, E. A., & Chu, S. Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.009 · Cited by 154
Immunomodulatory drugs and their application to the management of canine immune‐mediated disease
Whitley, N. T., & Day, M. J. (2011) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.2011.01024.x · Cited by 134
Toll‐like Receptors in Autoimmunity
Fischer, M., & Ehlers, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.012 · Cited by 147
Gornik, O., Štambuk, T., & Lauc, G. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.004 · Cited by 154
What is the contents of the magic draft IVIg?
Séïté, J.-F., Shoenfeld, Y., Youinou, P., & Hillion, S. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.012 · Cited by 133
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.